Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage [1][3]. Core Views - The company has shown significant revenue growth in the semiconductor sector, with a year-on-year increase of 48.01% in the first half of 2024, driven by a recovery in semiconductor industry demand [2][3]. - The company is one of the few domestic manufacturers capable of covering three major application areas: semiconductor, biopharmaceutical, and food and beverage, indicating strong future growth potential [3][5]. Summary by Sections Financial Performance - In the first half of 2024, the company achieved operating revenue of 1.418 billion yuan, a year-on-year increase of 11.83%, and a net profit attributable to shareholders of 140 million yuan, up 26.91% [2][3]. - The company's gross margin for H1 2024 was 25.57%, an increase of 0.75 percentage points year-on-year, while the net profit margin rose to 9.89%, up 1.18 percentage points [3][5]. Business Segments - The food segment generated revenue of 803 million yuan, a slight increase of 0.07% year-on-year, while the pharmaceutical segment saw revenue of 169 million yuan, up 2.76% [3]. - The semiconductor segment's revenue reached 447 million yuan, reflecting a robust growth of 48.01% due to improving order conditions in the semiconductor industry [3]. Future Projections - The company is projected to achieve operating revenues of 3.211 billion yuan, 3.892 billion yuan, and 4.703 billion yuan for the years 2024, 2025, and 2026, respectively [5]. - Net profit attributable to shareholders is expected to reach 326 million yuan, 448 million yuan, and 594 million yuan over the same period, indicating a strong growth trajectory [5].
新莱应材:2024年半年报点评:泛半导体收入同比高增,持续加大研发投入